Centralised authorisation procedure 2022

The Danish share of assignments in the European pharmaceutical collaboration

The Danish Medicines Agency should have the greatest possible influence on decisions regarding new medicinal products and thereby the greatest possible influence on the future development of the European market for medicinal products.

Status for 2022 up to and including 4^th quarter

Denmark was assigned 11 human rapporteur/co-rapporteur cases and 6 veterinary rapporteur/co-rapporteur case, which is respectively 6 % and 9 % of all assigned central procedure cases in 2022.

Figure 1: Amount of assigned (co)rapporteurships in the EU in 2022 up to and including 4^th quarter

Figure 2. Share of human Rap/Co-rap cases

Table 1: Assigned human Rapporteur/co-rapporteur cases

Figure 3. Share of veterinary Rap/Co-rap cases

Table 2: Assigned veterinary Rapporteur cases/co-rapporteur cases

Please contact god-validering@dkma.dk for further information.